DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, supplying promising advancements across a variety of healthcare and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, additional dependable substitute for therapeu